Profound Medical Corp. (PROF)
USD 5.37
(-2.81%)
USD 5.37
(-2.81%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 33.6 Million USD | 3.0% |
| 2022 | 32.62 Million USD | -1.87% |
| 2021 | 33.24 Million USD | 48.82% |
| 2020 | 22.33 Million USD | 27.23% |
| 2019 | 17.55 Million CAD | 13.77% |
| 2018 | 15.43 Million CAD | -0.5% |
| 2017 | 15.5 Million CAD | 33.27% |
| 2016 | 11.63 Million CAD | 43.9% |
| 2015 | 8.08 Million CAD | 86.4% |
| 2014 | 4.33 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 9.26 Million USD | -173.08% |
| 2024 Q1 | 8.71 Million USD | -11.08% |
| 2023 Q1 | 8.05 Million USD | 17.41% |
| 2023 FY | 33.6 Million USD | 3.0% |
| 2023 Q4 | 10.11 Million USD | 32.72% |
| 2023 Q3 | 7.62 Million USD | 1.79% |
| 2023 Q2 | 7.48 Million USD | -7.02% |
| 2022 Q1 | 7.72 Million USD | -24.42% |
| 2022 Q3 | 9.32 Million USD | 7.0% |
| 2022 Q4 | 6.85 Million USD | -26.46% |
| 2022 Q2 | 8.71 Million USD | 12.76% |
| 2022 FY | 32.62 Million USD | -1.87% |
| 2021 FY | 33.24 Million USD | 48.82% |
| 2021 Q1 | 6.82 Million USD | 15.53% |
| 2021 Q3 | 8.59 Million USD | 13.08% |
| 2021 Q4 | 10.22 Million USD | 18.98% |
| 2021 Q2 | 7.6 Million USD | 11.37% |
| 2020 Q1 | 5.03 Million CAD | -8.6% |
| 2020 Q3 | 6.58 Million CAD | 48.99% |
| 2020 Q4 | 5.9 Million USD | -10.27% |
| 2020 FY | 22.33 Million USD | 27.23% |
| 2020 Q2 | 4.41 Million CAD | -12.32% |
| 2019 Q1 | 2.74 Million CAD | -16.23% |
| 2019 Q4 | 5.51 Million CAD | 14.9% |
| 2019 Q3 | 4.79 Million CAD | 6.28% |
| 2019 Q2 | 4.51 Million CAD | 64.61% |
| 2019 FY | 17.55 Million CAD | 13.77% |
| 2018 Q3 | 4.05 Million CAD | -6.4% |
| 2018 Q1 | 3.69 Million CAD | -6.4% |
| 2018 FY | 15.43 Million CAD | -0.5% |
| 2018 Q4 | 3.27 Million CAD | -19.27% |
| 2018 Q2 | 4.33 Million CAD | 17.36% |
| 2017 Q3 | 4.15 Million CAD | 7.02% |
| 2017 FY | 15.5 Million CAD | 33.27% |
| 2017 Q4 | 3.94 Million CAD | -4.97% |
| 2017 Q2 | 3.87 Million CAD | 24.57% |
| 2017 Q1 | 3.11 Million CAD | -8.79% |
| 2016 Q1 | 2.77 Million CAD | 70.64% |
| 2016 Q3 | 2.87 Million CAD | 8.44% |
| 2016 Q4 | 3.41 Million CAD | 18.76% |
| 2016 FY | 11.63 Million CAD | 43.9% |
| 2016 Q2 | 2.65 Million CAD | -4.49% |
| 2015 Q2 | 3.62 Million CAD | 33555.28% |
| 2015 Q1 | 10.76 Thousand CAD | 29.07% |
| 2015 Q4 | 1.62 Million CAD | -20.81% |
| 2015 FY | 8.08 Million CAD | 86.4% |
| 2015 Q3 | 2.05 Million CAD | -43.32% |
| 2014 Q1 | 814.83 Thousand CAD | 0.0% |
| 2014 Q4 | 8342.87 CAD | -96.96% |
| 2014 FY | 4.33 Million CAD | 0.0% |
| 2014 Q3 | 274.75 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -199.387% |
| Cerus Corporation | 143.15 Million USD | 76.527% |
| OrthoPediatrics Corp. | 137.01 Million USD | 75.476% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -195.78% |
| Talis Biomedical Corporation | 67.18 Million USD | 49.985% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -34.704% |
| Inogen, Inc. | 236.08 Million USD | 85.767% |
| Spectral AI, Inc. | 20.86 Million USD | -61.058% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 39.991% |
| CVRx, Inc. | 76.14 Million USD | 55.868% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -852.471% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -169.062% |
| Orthofix Medical Inc. | 667.42 Million USD | 94.965% |
| Venus Concept Inc. | 80.47 Million USD | 58.245% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 40.607% |
| Bioventus Inc. | 409.91 Million USD | 91.802% |
| BrainsWay Ltd. | 28.01 Million USD | -19.934% |
| Envoy Medical, Inc. | 17.89 Million USD | -87.748% |
| electroCore, Inc. | 32.03 Million USD | -4.908% |
| IceCure Medical Ltd | 16.87 Million USD | -99.118% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 20.807% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -90.569% |
| MaxCyte, Inc. | 84.84 Million USD | 60.395% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -170.736% |
| Nexalin Technology, Inc. | 5.78 Million USD | -481.233% |
| PAVmed Inc | 64.82 Million USD | 48.165% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 34.212% |
| RxSight, Inc. | 103.85 Million USD | 67.643% |
| Sight Sciences, Inc. | 126.44 Million USD | 73.426% |
| SI-BONE, Inc. | 156.35 Million USD | 78.508% |
| TELA Bio, Inc. | 84.18 Million USD | 60.085% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 52.034% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 83.476% |
| LivaNova PLC | 843.54 Million USD | 96.016% |
| 908 Devices Inc. | 68.08 Million USD | 50.642% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 93.051% |
| Nemaura Medical Inc. | 7.13 Million USD | -370.711% |
| NeuroPace, Inc. | 75.29 Million USD | 55.372% |
| LENSAR, Inc. | 33.33 Million USD | -0.801% |
| Apyx Medical Corporation | 51.01 Million USD | 34.135% |
| Cutera, Inc. | 197.72 Million USD | 83.005% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -35.6% |
| BioSig Technologies, Inc. | 28.53 Million USD | -17.782% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 82.45% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 6.813% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 95.982% |
| Axonics, Inc. | 270.2 Million USD | 87.564% |
| Outset Medical, Inc. | 198.77 Million USD | 83.094% |
| IRIDEX Corporation | 31.81 Million USD | -5.624% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 81.354% |
| IRadimed Corporation | 30.12 Million USD | -11.554% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -293.848% |
| INVO Bioscience, Inc. | 7.85 Million USD | -327.886% |
| Telesis Bio, Inc. | 63.48 Million USD | 47.072% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 65.869% |
| Varex Imaging Corporation | 224.8 Million USD | 85.052% |
| Quipt Home Medical Corp. | 148.66 Million USD | 77.397% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -186.643% |
| Pulmonx Corporation | 112.68 Million USD | 70.18% |
| Dynatronics Corporation | 9.9 Million USD | -239.151% |
| Modular Medical, Inc. | 17.52 Million USD | -91.7% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -66.459% |
| Semler Scientific, Inc. | 38.94 Million USD | 13.714% |
| InMode Ltd. | 215.68 Million USD | 84.42% |
| Bruker Corporation | 1.07 Billion USD | 96.878% |
| Cytosorbents Corporation | 48.33 Million USD | 30.481% |
| DexCom, Inc. | 1.69 Billion USD | 98.013% |
| Align Technology, Inc. | 2.07 Billion USD | 98.382% |
| Viveve Medical, Inc. | 22.17 Million USD | -51.55% |
| ZimVie Inc. | 275.12 Million USD | 87.786% |
| Movano Inc. | 29.69 Million USD | -13.18% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 75.521% |
| Nexalin Technology, Inc. | 5.78 Million USD | -481.233% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -852.471% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 94.408% |
| Insulet Corporation | 939.9 Million USD | 96.425% |
| enVVeno Medical Corporation | 25.23 Million USD | -33.145% |
| Surmodics, Inc. | 98.69 Million USD | 65.953% |
| iCAD, Inc. | 22.22 Million USD | -51.195% |
| Nuwellis, Inc. | 22.61 Million USD | -48.601% |
| Biotricity, Inc. | 17.18 Million USD | -95.543% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 92.464% |
| Aethlon Medical, Inc. | 12.27 Million USD | -173.697% |
| InspireMD, Inc. | 22.95 Million USD | -46.419% |
| PAVmed Inc. | 64.82 Million USD | 48.165% |
| BIOLASE, Inc. | 34.66 Million USD | 3.052% |
| Beyond Air, Inc. | 61.7 Million USD | 45.538% |
| FONAR Corporation | 28.6 Million USD | -17.474% |
| AxoGen, Inc. | 149.33 Million USD | 77.498% |
| Vivani Medical, Inc. | 26.96 Million USD | -24.618% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 81.025% |
| Inari Medical, Inc. | 448.59 Million USD | 92.509% |
| UFP Technologies, Inc. | 58.08 Million USD | 42.152% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -581.937% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -431.839% |
| Tenon Medical, Inc. | 16.96 Million USD | -98.038% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -354.526% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 23.807% |
| AdaptHealth Corp. | 1.07 Billion USD | 96.883% |
| Sintx Technologies, Inc. | 15.2 Million USD | -121.059% |
| NanoVibronix, Inc. | 4.97 Million USD | -575.712% |
| Quanterix Corporation | 118.1 Million USD | 71.547% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -186.643% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -132.677% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 91.442% |
| TransMedics Group, Inc. | 182.82 Million USD | 81.62% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -19.733% |
| NeuroMetrix, Inc. | 11.09 Million USD | -202.76% |
| Hyperfine, Inc. | 52.87 Million USD | 36.444% |
| Establishment Labs Holdings Inc. | 172 Million USD | 80.464% |
| Biomerica, Inc. | 6.97 Million USD | -381.558% |
| Bone Biologics Corporation | 9.42 Million USD | -256.407% |
| AVITA Medical, Inc. | 80.77 Million USD | 58.401% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -225.889% |
| Silk Road Medical, Inc | 186.35 Million USD | 81.968% |